Literature DB >> 12646556

Regulation of dopamine D1 receptor trafficking and desensitization by oligomerization with glutamate N-methyl-D-aspartate receptors.

Chiara Fiorentini1, Fabrizio Gardoni, PierFranco Spano, Monica Di Luca, Cristina Missale.   

Abstract

Activation of dopamine D1 receptors is critical for the generation of glutamate-induced long-term potentiation at corticostriatal synapses. In this study, we report that, in striatal neurons, D1 receptors are co-localized with N-methyl-d-aspartate (NMDA) receptors in the postsynaptic density and that they co-immunoprecipitate with NMDA receptor subunits from postsynaptic density preparations. Using modified bioluminescence resonance energy transfer, we demonstrate that D1 and NMDA receptor clustering reflects the existence of direct interactions. The tagged D1 receptor and NR1 subunit cotransfected in COS-7 cells generated a significant bioluminescence resonance energy transfer signal that was insensitive to agonist stimulation and that did not change in the presence of the NR2B subunit, suggesting that the D1 receptor constitutively and selectively interacts with the NR1 subunit of the NMDA channel. Oligomerization with the NR1 subunit substantially modified D1 receptor trafficking. In individually transfected HEK293 cells, NR1 was localized in the endoplasmic reticulum, whereas the D1 receptor was targeted to the plasma membrane. In cotransfected cells, both the D1 receptor and NR1 subunit were retained in cytoplasmic compartments. In the presence of the NR2B subunit, the NR1-D1 receptor complex was translocated to the plasma membrane. These data suggest that D1 and NMDA receptors are assembled within intracellular compartments as constitutive heteromeric complexes that are delivered to functional sites. Coexpression with NR1 and NR2B subunits also abolished agonist-induced D1 receptor cytoplasmic sequestration, indicating that oligomerization with the NMDA receptor could represent a novel regulatory mechanism modulating D1 receptor desensitization and cellular trafficking.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12646556     DOI: 10.1074/jbc.M213140200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  84 in total

1.  Effects of protein kinase A inhibitor and activator on rewarding effects of SKF-82958 microinjected into nucleus accumbens shell of ad libitum fed and food-restricted rats.

Authors:  Soledad Cabeza de Vaca; Xing-Xiang Peng; Seth Concors; Casey Farin; Elena Lascu; Kenneth D Carr
Journal:  Psychopharmacology (Berl)       Date:  2011-12-07       Impact factor: 4.530

2.  Regulation of dopamine D1 receptor function by physical interaction with the NMDA receptors.

Authors:  Lin Pei; Frank J S Lee; Anna Moszczynska; Brian Vukusic; Fang Liu
Journal:  J Neurosci       Date:  2004-02-04       Impact factor: 6.167

3.  N-methyl-D-aspartate (NMDA) receptor composition modulates dendritic spine morphology in striatal medium spiny neurons.

Authors:  Csaba Vastagh; Fabrizio Gardoni; Vincenza Bagetta; Jennifer Stanic; Elisa Zianni; Carmen Giampà; Barbara Picconi; Paolo Calabresi; Monica Di Luca
Journal:  J Biol Chem       Date:  2012-04-09       Impact factor: 5.157

Review 4.  Pharmacology of signaling induced by dopamine D(1)-like receptor activation.

Authors:  Ashiwel S Undieh
Journal:  Pharmacol Ther       Date:  2010-06-12       Impact factor: 12.310

5.  Thromboxane A2 receptor and MaxiK-channel intimate interaction supports channel trans-inhibition independent of G-protein activation.

Authors:  Min Li; Yoshio Tanaka; Abderrahmane Alioua; Yong Wu; Rong Lu; Pallob Kundu; Enrique Sanchez-Pastor; Jure Marijic; Enrico Stefani; Ligia Toro
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-19       Impact factor: 11.205

6.  Amazing stability of the arginine-phosphate electrostatic interaction.

Authors:  Amina S Woods; Sergi Ferré
Journal:  J Proteome Res       Date:  2005 Jul-Aug       Impact factor: 4.466

7.  Allosteric changes of the NMDA receptor trap diffusible dopamine 1 receptors in spines.

Authors:  Lena Scott; Sergey Zelenin; Seth Malmersjö; Jacob M Kowalewski; Eivor Zettergren Markus; Angus C Nairn; Paul Greengard; Hjalmar Brismar; Anita Aperia
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-09       Impact factor: 11.205

8.  Inhibition of the dopamine D1 receptor signaling by PSD-95.

Authors:  Jingping Zhang; Angel Vinuela; Mark H Neely; Penelope J Hallett; Seth G N Grant; Gregory M Miller; Ole Isacson; Marc G Caron; Wei-Dong Yao
Journal:  J Biol Chem       Date:  2007-03-16       Impact factor: 5.157

9.  Should we be cautious on the use of commercially available antibodies to dopamine receptors?

Authors:  Serena Bodei; Nicola Arrighi; PierFranco Spano; Sandra Sigala
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-12-19       Impact factor: 3.000

10.  NMDAR dependent intracellular responses associated with cocaine conditioned place preference behavior.

Authors:  Stephanie K Nygard; Anthony Klambatsen; Bailey Balouch; Vanya Quinones-Jenab; Shirzad Jenab
Journal:  Behav Brain Res       Date:  2016-09-21       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.